News
In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...
15h
MedPage Today on MSNGood News on GLP-1s and Cancer Risk, With One Exception
With follow-up ranging from 1 to 11 years, use of GLP-1 agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide ...
Real world data that harnesses deidentified health records is a multi-billion-dollar industry. But what is the value of a ...
The pneumococcal infection market is poised for steady growth, driven by a combination of high global disease burden, rising antimicrobial resistance, and expanded immunization initiatives. Analyst ...
Pharmaceutical technology exports have exceeded KRW 10 trillion this year, according to an Aug. 19 report based on Global ...
4h
InvestorsHub on MSNDynavax shares jump 8% after promising shingles vaccine trial results
Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from its Phase 1/2 trial of Z-1018, the company’s experimental shingles vaccine ...
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors ...
Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration ...
Drug testing laboratories from provinces have informed the DRAP that the samples of above mentioned products have been declared the list of “spurious” drugs. It said Drug Testing Laboratories of ...
China’s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on ...
As of December 31, 2024, HALEON has a total of 117.055 million shares outstanding which are held by 5124 shareholders. Haleon ...
DelveInsight’s, “Gastrointestinal Stromal Tumors Pipeline Insight 2025” report provides comprehensive insights about 25+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results